NRx Pharmaceuticals (NRXP) SEC Filings & 10K Form

$4.16
+0.62 (+17.51%)
(As of 03:03 PM ET)

Recent NRx Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/30/2024
4:26 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:46 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 10-K/A
04/19/2024
4:10 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
9:08 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
04/18/2024
7:21 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
04/15/2024
4:22 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
4:13 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
04/15/2024
5:00 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
04/02/2024
5:01 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
4:09 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:08 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEFA14A
03/11/2024
4:16 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEF 14A
02/28/2024
4:09 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
9:40 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
02/26/2024
4:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
02/14/2024
5:03 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:37 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
3:16 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
5:36 PM
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Rehnquist Janet (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form PRE 14A
12/29/2023
3:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:30 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K/A
11/22/2023
3:31 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEF 14A
11/22/2023
3:32 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form ARS
11/21/2023
4:23 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
3:05 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:04 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
8:19 AM
Gorovitz Aaron (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
8:15 AM
Hurvitz Chaim (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:48 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
08/31/2023
4:20 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
11:14 AM
Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
8:24 AM
Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
4:10 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
4:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
9:21 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
06/07/2023
4:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K/A
06/06/2023
3:27 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:00 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Does this make you sick? (Ad)

The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.

Get your Free Wealth Protection Kit
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NRXP) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners